Mercaptopurine Anhydrous

CHEMBL1425 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
152.2 g/mol
LogP
Phase
4

An anhydrous form of mercaptopurine, a chemotherapy drug used to treat leukemia and other blood cancers by disrupting cancer cell DNA synthesis.

Молекулярная масса

152,1800 g/mol

LogP

0,00

TPSA

85,20 Ų

Правило пяти Липинского

Соответствует

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Sc1ncnc2nc[nH]c12

InChI

InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)

Molecular Formula

C5H4N4S

HBD / HBA

2 / 2

Вращаемые Связи

0

Тяжёлые Атомы

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

An anhydrous form of mercaptopurine, a chemotherapy drug used to treat leukemia and other blood cancers by disrupting cancer cell DNA synthesis.

Yes, Mercaptopurine Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1425. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 667490. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.